NTLA
Intellia Therapeutics Inc
Biotechnology company focused on CRISPR gene editing
CUSIP: 45826J105HealthcareUS1 holder
Total Value
$171.65M
Total Shares
1.28M
Net Share Change
+304.4K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Viking Global Investors
$171.65M1.28M shares
ADD+304.4K(+31.2%)